[
  {
    "date": "2023-12-30",
    "symbol": "NAMS",
    "period": "FY",
    "netincomeloss": -176937000,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "NewAmsterdam Pharma Company N.V.",
    "entitycentralindexkey": 1936258,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "001-41562",
    "entitytaxidentificationnumber": "00-0000000",
    "entityaddressaddressline1": "Gooimeer 2-35",
    "entityaddresscityortown": "Naarden",
    "entityaddresscountry": "NL",
    "entityaddresspostalzipcode": "1411 DC",
    "cityareacode": 31,
    "localphonenumber": "(0) 35 206 2971",
    "entityincorporationstatecountrycode": "P7",
    "security12btitle": "Ordinary shares, nominal value €0.12 per share",
    "tradingsymbol": "NAMS",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "true",
    "documentfinstmtrestatementrecoveryanalysisflag": "false",
    "auditorfirmid": 1243,
    "auditorname": "Deloitte Accountants B.V",
    "auditorlocation": "Eindhoven, The Netherlands",
    "cash": 340450000,
    "prepaidexpenseandotherassetscurrent": 6341000,
    "assetscurrent": 346791000,
    "propertyplantandequipmentnet": 46000,
    "operatingleaserightofuseasset": 55000,
    "intangibleassetsnetincludinggoodwill": 170000,
    "prepaidexpensenoncurrent": 35000,
    "assets": 347097000,
    "accountspayablecurrent": 16923000,
    "accountspayableandotheraccruedliabilitiescurrent": 11398000,
    "deferredrevenuecurrent": 8942000,
    "operatingleaseliabilitycurrent": 60000,
    "derivativeliabilitiescurrent": 12574000,
    "liabilitiescurrent": 49897000,
    "deferredrevenuenoncurrent": 1019000,
    "derivativeliabilitiesnoncurrent": 7788000,
    "liabilities": 58704000,
    "commonstockvalue": 10173000,
    "additionalpaidincapitalcommonstock": 590771000,
    "retainedearningsaccumulateddeficit": -316973000,
    "accumulatedothercomprehensiveincomelossnetoftax": 4422000,
    "stockholdersequity": 288393000,
    "liabilitiesandstockholdersequity": 347097000,
    "commonstockparorstatedvaluepershare": 0.12,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 82469768,
    "commonstocksharesoutstanding": 82469768,
    "revenuefromcontractwithcustomerexcludingassessedtax": 14090000,
    "researchanddevelopmentexpense": 159424000,
    "sellinggeneralandadministrativeexpense": 37633000,
    "operatingexpenses": 197057000,
    "operatingincomeloss": -182967000,
    "investmentincomeinterest": 11283000,
    "changeinfairvalueofearnoutandwarrants": 10284000,
    "foreigncurrencytransactiongainlossbeforetax": 5058000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -176910000,
    "incometaxexpensebenefit": 27000,
    "comprehensiveincomenetoftax": -176937000,
    "earningspersharebasic": -2.15,
    "earningspersharediluted": -2.15,
    "sharesoutstanding": 82469768,
    "stockissuedduringperiodvaluewarrantsexercised": 97000,
    "stockissuedduringperiodshareswarrantsexercised": 749741,
    "stockissuedduringperiodvaluestockoptionsexercised": 21000,
    "stockissuedduringperiodsharesstockoptionsexercised": 160247,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 24761000,
    "profitloss": -176937000,
    "depreciationdepletionandamortization": 49000,
    "noncashrentexpense": 6000,
    "changeinfairvalueofderivativeearnoutandwarrants": 10284000,
    "sharebasedcompensation": 24572000,
    "increasedecreaseinprepaymentsandotherreceivables": -4031000,
    "increasedecreaseinaccountspayable": 5070000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 5470000,
    "increasedecreaseindeferredrevenue": -8705000,
    "netcashprovidedbyusedinoperatingactivities": -141218000,
    "paymentstoacquireproductiveassets": 24000,
    "netcashprovidedbyusedininvestingactivities": -24000,
    "proceedsfromwarrantexercises": 8622000,
    "proceedsfromstockoptionsexercised": 290000,
    "netcashprovidedbyusedinfinancingactivities": 8912000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -132330000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 5052000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 340450000,
    "incometaxespaid": 27000,
    "lesseeoperatingleasetermofcontract": "P1Y",
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "incometaxexaminationlikelihoodofunfavorablesettlement": "greater than 50% likelihood",
    "propertyplantandequipmentusefullife": "P5Y",
    "earnoutshares": 143002,
    "revenueperformanceobligationdescriptionofgoodorservice": "As such, two performance obligations for the Menarini License were identified at contract inception, comprising a license to use the Company’s intellectual property",
    "numberofperformanceobligations": 2,
    "contingentpayment": 863000000,
    "deferredrevenue": 9961000,
    "licenserevenueattributedfromlicenseperformanceobligations": 5385000,
    "licenserevenueattributedfromranddperformanceobligations": 8705000,
    "deferredrevenuerecognized": 8705000,
    "earnoutliabilityfairvaluedisclosure": 7788000,
    "financialliabilitiesfairvaluedisclosure": 12051000,
    "derivativeliabilitymeasurementinput": 11.17,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 7788000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -266000,
    "fairvaluerecurringbasisunobservableinputreconciliationliabilitygainlossstatementofincomeextensiblelist": "http://www.newamsterdampharma.com/20231231#ChangeInFairValueOfEarnoutAndWarrants",
    "prepaidresearchanddevelopmentcostscurrent": 2337000,
    "otherprepaidexpensecurrent": 2123000,
    "valueaddedtaxreceivablecurrent": 1006000,
    "otherreceivablesnetcurrent": 875000,
    "accruedresearchanddevelopmentmaterialsandservicescurrent": 5945000,
    "accruedemployeebenefitscurrent": 3384000,
    "accruedprofessionalfeescurrent": 2069000,
    "commonstocknumberofvotepershare": 1,
    "commonstockvotingrights": "each holder of Ordinary Shares is entitled to one vote per share on all matters to be voted on by shareholders",
    "commonstockcapitalsharesreservedforfutureissuance": 16425868,
    "percentageofordinarysharesreservedforgrantwillincreaseannuallyofissuedandoutstandingshares": 0.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 490067,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 255243,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 234824,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 12.19,
    "incrementalfairvaluefullyrecognized": 2900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 4.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 1700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P1Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsunrecognizedcompensationcost": 25200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsliabilityforunvestedordinaryshares": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 519999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 15783509,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 2032129,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5230531,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.98,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.63,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.81,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 50796000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 37101000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.041,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.381,
    "allocatedsharebasedcompensationexpense": 14521000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 608779,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -107555000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -69355000,
    "currentfederaltaxexpensebenefit": 27000,
    "currentincometaxexpensebenefit": 27000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.258,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.0294,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0071,
    "effectiveincometaxratereconciliationwarrants": -0.015,
    "effectiveincometaxratereconciliationtaxcredits": 0.0531,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.274,
    "effectiveincometaxratecontinuingoperations": -0.0002,
    "deferredtaxassetsamortizationanddepreciation": 21176000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 509000,
    "deferredtaxassetsoperatinglosscarryforwards": 75686000,
    "deferredtaxassetsleaseliabilityarrangements": 13000,
    "deferredtaxassetsinprocessresearchanddevelopment": 22884000,
    "deferredtaxassetstaxcreditfederal": 6904000,
    "deferredtaxassetstaxcreditmassachusetts": 2685000,
    "deferredtaxassetsgross": 129857000,
    "deferredtaxassetsvaluationallowance": 129845000,
    "deferredtaxassetsnet": 12000,
    "deferredtaxliabilitiesrightofuseasset": 12000,
    "operatinglosscarryforwards": 274600000,
    "taxcreditcarryforwardamount": 6900000,
    "sharesexchangingratio": 0.0213,
    "weightedaveragenumberofsharesoutstandingbasic": 82161956,
    "weightedaveragenumberofdilutedsharesoutstanding": 82161956,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 15783509,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 1,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.5,
    "definedcontributionplanemployermatchingcontributionpercent": 0.03,
    "definedcontributionplanemployermatchingadditionalcontributionuponemployeepercent": 0.02,
    "definedcontributionplancostrecognized": 120000,
    "estimatedmaximumcancellationfees": 15700000,
    "percentageofdevelopmentcostsincurred": 0.5
  },
  {
    "date": "2022-12-31",
    "symbol": "NAMS",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "NewAmsterdam Pharma Company N.V.",
    "entitycentralindexkey": 1936258,
    "currentfiscalyearenddate": "December 31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityincorporationstatecountrycode": "Netherlands",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": " Non-accelerated filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "true",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Warrants to purchase ordinary shares",
    "tradingsymbol": "NAMSW",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityfilenumber": "001-41562",
    "entityaddressaddressline1": "Gooimeer 2-35",
    "entityaddresscityortown": "Naarden",
    "entityaddresspostalzipcode": "1411 DC",
    "cityareacode": 31,
    "localphonenumber": "(0) 35 206 2971",
    "entityaddresscountry": "Netherlands",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentregistrationstatement": "false",
    "documentshellcompanyreport": "false",
    "icfrauditorattestationflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "contactpersonnelname": "Michael Davidson",
    "entitycommonstocksharesoutstanding": "null",
    "contactpersonnelemailaddress": "info@NewAmsterdamPharma.com",
    "auditorfirmid": 1243,
    "auditorname": "Deloitte Accountants B.V.",
    "auditorlocation": "Rotterdam, The Netherlands",
    "revenuefromcontractswithcustomers": 97500000,
    "researchanddevelopmentexpense": 130000,
    "sellinggeneralandadministrativeexpense": 22230000,
    "sharelistingexpense": 60600000,
    "operatingexpense": 165060000,
    "profitlossfromoperatingactivities": -67560000,
    "financeincome": 11000,
    "financecosts": 271000,
    "fairvaluechangeearnoutandwarrants": 976000,
    "gainslossesonexchangedifferencesontranslationbeforetax": -9256000,
    "profitlossbeforetax": -78052000,
    "profitloss": -78052000,
    "comprehensiveincome": -78052000,
    "basicearningslosspershare": -0.96,
    "dilutedearningslosspershare": -0.96,
    "intangibleassetsotherthangoodwill": 83160000,
    "propertyplantandequipment": 31000,
    "noncurrentprepaidexpenses": 100000,
    "noncurrentassets": 83450000,
    "currentprepaymentsandotherreceivables": 9611000,
    "cash": 438522000,
    "currentassets": 448133000,
    "assets": 531583000,
    "issuedcapital": 599191000,
    "otherreserves": 4691000,
    "accumulatedothercomprehensiveincome": -119361000,
    "equity": -119361000,
    "rentdeferredincomeclassifiedasnoncurrent": 4492000,
    "noncurrentleaseliabilities": 56000,
    "noncurrentderivativeearnoutliability": 7053000,
    "noncurrentliabilities": 11601000,
    "tradeandothercurrentpayables": 18503000,
    "rentdeferredincomeclassifiedascurrent": 13008000,
    "currentleaseliabilities": 62000,
    "currentderivativewarrantliabilities": 3888000,
    "currentliabilities": 35461000,
    "equityandliabilities": 531583000,
    "increasedecreasethrougheliminationoldshares": -163556000,
    "increasedecreasethroughothercontributionsbyowners": 83160000,
    "increasedecreasethroughtransactioncostsonissueofshares": -2534000,
    "increasedecreasethroughearnoutobligationonclosing": -6633000,
    "increasedecreasethroughsharebasedpaymenttransactions": 4100000,
    "adjustmentsfordepreciationandamortisationexpense": 72000,
    "adjustmentforsharelistingexpense": 60600000,
    "financeexpense": 9000,
    "adjustmentsforfairvaluegainslosses": 976000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 9256000,
    "adjustmentsforsharebasedpayments": 3922000,
    "adjustmentsfordecreaseincreaseinotheroperatingreceivables": -3975000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": -2063000,
    "adjustmentforincreasedecreaseindeferredrevenue": 17500000,
    "interestpaidclassifiedasoperatingactivities": 262000,
    "cashflowsfromusedinoperatingactivities": 7972000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 13000,
    "repaymentofloanreceivableclassifiedasinvestingactivities": 728000,
    "cashflowsfromusedininvestingactivities": 715000,
    "proceedsfromissuingshares": 228343000,
    "paymentsforshareissuecosts": 2534000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 65000,
    "cashflowsfromusedinfinancingactivities": 375177000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 383864000,
    "effectofexchangeratechangesoncashandcashequivalents": 1566000,
    "cashandcashequivalents": 438522000,
    "upfrontpaymentreceived": 115000000,
    "percentageofstraightlinedepreciationperannum": 0.2,
    "depreciationmethodpropertyplantandequipment": "straight line",
    "dateofentityincorporation": "October 7, 2020",
    "initialpublicofferingcompletiondate": "December 11, 2020",
    "dateofacquisition2013": "November 22, 2022",
    "parvaluepershare": 2.48,
    "numberofsharesissued": 285714,
    "shareissuerelatedcost": 2500000,
    "weightedaverageexchangeratio": 2.13,
    "numberofwarrantsoutstanding": 167000,
    "numberofordinaryshareconvertfromeachwarrant": 1,
    "upfrontpaymentofpaymentobligation": 115000000,
    "revenuefromperformanceobligationssatisfiedorpartiallysatisfiedinpreviousperiods": 1200000,
    "costfordevelopmentofproducts": 27500000,
    "numberofannualinstallmentsofrevenuepartiallycontribution": 2,
    "percentageofrevenuefromperformanceobligationssatisfiedorpartiallysatisfiedinpreviousperiods": 0.5,
    "percentageofincreasedecreaseinestimatedcosts": 0.5,
    "additionalmilestonepaymentuponachievement": 863000000,
    "costofsales": 3100000,
    "salesandmarketingexpense": 2500000,
    "currentprepaymentsandothercurrentassets": 500000,
    "transactionpriceallocatedtoremainingperformanceobligations": 27500000,
    "contractliabilities": 21500000,
    "currentcontractliabilities": 13000000,
    "noncurrentcontractliabilities": 4500000,
    "deferredrevenues": 17500000,
    "additionofdeferredrevenue": 21500000,
    "deferredrevenuerecognized": 4000000,
    "feeandcommissionexpense": 2485000,
    "personnelexpenses": 5017000,
    "travelexpense": 430000,
    "intellectualproperty": 1348000,
    "legalcosts": 2176000,
    "financeandadministration": 5209000,
    "transportationexpense": 3021000,
    "informationtechnologyexpense": 25000,
    "rentandofficeservices": 165000,
    "marketingandcommunication": 1269000,
    "insuranceexpense": 289000,
    "depreciationandamortisationexpense": 72000,
    "commercialcosts": 134000,
    "businessdevelopmentexpense": 260000,
    "boardfees": 69000,
    "miscellaneous": 261000,
    "wagesandsalaries": 7015000,
    "otherlongtermbenefits": 832000,
    "expensefromsharebasedpaymenttransactionswithemployees": 3922000,
    "employeebenefitsexpense": 11769000,
    "postemploymentbenefitexpensedefinedcontributionplans": 66,
    "employeehealthinsuranceandworkerscompensationinsurancecosts": 170,
    "employmenttaxes": 191,
    "currentnonclinicalrdcosts": 707000,
    "currentclinicalother": 4704000,
    "currentgeneralandadministrative": 2259000,
    "currentprepayments": 7670000,
    "currentvalueaddedtaxreceivables": 1941000,
    "currentaccountspayable": 11113000,
    "currentaccruedexpenses": 5455000,
    "liabilitiesfromsharebasedpaymenttransactions2011": 1655000,
    "incometaxreconciliationincometaxexpensebenefitsatfederalstatutoryincometaxrate": 395000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrateforthefirst": 0.15,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxratethereafter": 0.258,
    "taxlossescarriedforwardlimitpercentageoftaxableincome": 0.5,
    "taxlossescarriedforwardexcessamountovertaxableincomeinrespectiveyear": 1000000,
    "assessedtaxlossescarriedforward": 78100000,
    "taxexpenseincomeatapplicabletaxrate": 20095000,
    "taxbenefitarisingfrompreviouslyunrecognisedtaxlosstaxcreditortemporarydifferenceofpriorperiodusedtoreducedeferredtaxexpense": 20095000,
    "assumedtaxlosscarryforwardamountduringtaxperiod": 251592000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 13000,
    "depreciationpropertyplantandequipment": 72000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -13000,
    "accruedfinanceexpense": 10000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 728000,
    "increasedecreaseinbasispoints": -1,
    "increasedecreaseonprofitbeforetaxequity": 2867,
    "netexposuretoforeigncurrencyriskamount": 268200000,
    "derivativewarrantliabilities": 136,
    "derivativeearnoutliability": 7053,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 29775000,
    "percentageofincreasedecreaseinshareprice": -0.15,
    "increasedecreaseonprofitorlossbeforetaxequity": 1058000,
    "tradeandotherpayables": 16568000,
    "leaseliabilities": 118000,
    "financialliabilities": 29562000,
    "warrantexercisepriceperordinaryshare": 11.5,
    "thresholdperiodtoconvertwarranttoordinaryshare": 30,
    "minimumclosingmarketpriceofordinarysharestocallwarrantsforredemption": 18,
    "warrantorrightredemptionofwarrantsorrightsthresholdtradingdays": 20,
    "warrantorrightredemptionofwarrantsorrightsthresholdconsecutivetradingdays": 30,
    "minimumreferencevaluetoredeemoutstandingwarrants": 10,
    "maximumreferencevaluetoredeemoutstandingprivateplacementwarrants": 18,
    "warrantsexpirationdate": "November 23, 2027",
    "warrantsexpirationtermafterclosingdate": " five years",
    "fairvalueofwarrantsperwarrant": 0.87,
    "tradingincomeexpenseonderivativefinancialinstruments": 700000,
    "significantunobservableinputliabilities": 4.6,
    "fairvalueofearnoutpricepershare": 4.09,
    "changeinfairvalueofderivativeearnoutliabilityunderfairvaluechangethroughprofitorloss": 700000,
    "derivativeearnoutliabilityexpectedrangeofmilestonecompletion": 1.67,
    "increasedecreaseinfairvaluemeasurementduetoreasonablypossibleincreaseinunobservableinputrecognisedinprofitorlossbeforetaxentitysownequityinstruments": -3526000,
    "increasedecreaseinfairvaluemeasurementduetoreasonablypossibledecreaseinunobservableinputrecognisedinprofitorlossbeforetaxentitysownequityinstruments": -3526000,
    "percentageofincreaseinprobabilityofmilestoneachievement": 0.2,
    "percentageofdecreaseinprobabilityofmilestoneachievement": 0.2,
    "financialliabilitiesatfairvaluethroughprofitorloss": 10941,
    "liabilitiesarisingfromfinancingactivities": 11059000,
    "principalpaymentsofleaseliabilitiesclassifiedasfinancingactivities": 56000,
    "interestexpenseonleaseliabilities": 9000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -65000,
    "increasedecreasethrougheffectofchangesinforeignexchangeratesliabilitiesarisingfromfinancingactivities": -370000,
    "interestpaidclassifiedasfinancingactivities": 9000,
    "increasedecreasethroughacquiredatclosingdateliabilitiesarisingfromfinancingactivities": 10345000,
    "increasedecreasethroughchangesinfairvaluesliabilitiesarisingfromfinancingactivities": 976000,
    "increasedecreaseinliabilitiesarisingfromfinancingactivities": 10960000,
    "balanceswithbanks": 438522000,
    "numberofsharesoutstanding": "null",
    "sharecapital": 9787000,
    "sharepremium": 589404000,
    "sharecapitalandsharepremium": 599191000,
    "discountforlackofmarketabilitypercentage": 0.15,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": "null",
    "numberofoutstandingshareoptions": "null",
    "earnoutshares": 160778,
    "exercisepriceofoutstandingshareoptions2019": 1.16392,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": "null",
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 10,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": 9.4,
    "descriptionofvestingrequirementsforsharebasedpaymentarrangement": "Each new option granted in 2022 under the Plans has a four-year vesting period with 1/48 vesting on each one-month anniversary of the grant date. ",
    "vestingperiodofsharebasedpaymentarrangement": "four-year",
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 3922000,
    "expensefortheemployersocialsecuritycontributions": 1612000,
    "issuedcapitalordinaryshares": 280000,
    "conversionofordinaryshares": 608779,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 367804,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 6.52,
    "weightedaveragesharepriceshareoptionsgranted2019": 9.61,
    "exercisepriceshareoptionsgranted2019": 9.73,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.42,
    "descriptionofoptionlifeshareoptionsgranted": 7,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0393,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 4.2,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 608779,
    "weightedaverageshares": "null",
    "profitlossattributabletoownersofparent": -78052,
    "dilutiveeffectofshareoptionsonnumberofordinaryshares": "null",
    "rightofuseassets": 113000,
    "depreciationrightofuseassets": 64000,
    "impactoftransactionofforeigncurrency": 15000,
    "repaymentofleaseliabilities": 55000,
    "descriptionofnatureofrelatedpartyrelationship": "Common control",
    "descriptionoftransactionswithrelatedparty": "Rent and office services",
    "servicesreceivedrelatedpartytransactions": 40,
    "amountspayablerelatedpartytransactions": 12,
    "leaseterminationnoticeperiod": "30 days",
    "keymanagementpersonnelcompensationcashremunerationreceived": 61000,
    "keymanagementpersonnelcompensationsharebasedpayment": 62000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2741,
    "keymanagementpersonnelcompensation": 5944,
    "noncurrentassetsbygeographiclocation": 83450000,
    "iprdassetrecognizedresultingfromequityissuedtoshareholders": 83160000,
    "derivativeearnoutobligationassumedonclosing": 6633000,
    "equityissuedtoshareholdersinexcessofproceedsreceived": 56913000
  }
]